Amit Mukharya

Title: Innovations by Amit Mukharya in Pharmaceutical Composition

Introduction

Amit Mukharya is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in developing stable compositions for treating atherosclerosis. His work focuses on enhancing the efficacy and safety of multi-component pharmaceutical formulations.

Latest Patents

Amit Mukharya holds a patent for a stable pharmaceutical composition aimed at treating atherosclerosis. This invention involves a solid oral multi-component composition that combines blood pressure-lowering drugs with lipid-lowering agents and optionally a platelet aggregation inhibitor in a single dosage form. The formulation is designed to overcome drug-drug interactions, exhibit favorable pharmacokinetic and pharmacodynamic profiles, and minimize side effects. The invention aims to improve adherence to therapy by maintaining the activity of all active ingredients without significantly increasing the adverse event profile.

Career Highlights

Amit Mukharya is currently associated with Cadila Pharmaceuticals Limited, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulations that address critical health issues.

Collaborations

Amit has collaborated with notable colleagues such as Bakulesh Mafatlal Khamar and Kumud Kumar Padhee, enhancing the research and development efforts within his organization.

Conclusion

Amit Mukharya's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective drug formulations. His patent for a stable pharmaceutical composition reflects his expertise and dedication to advancing medical science.